Basics |
Company: |
Cabaletta Bio, Inc. Common Stock |
IPO Date: |
November 1, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$100.69M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.34 | 4.45%
|
Avg Daily Range (30 D): |
$0.11 | 4.53%
|
Avg Daily Range (90 D): |
$0.17 | 5.54%
|
Institutional Daily Volume |
Avg Daily Volume: |
.69M |
Avg Daily Volume (30 D): |
1.3M |
Avg Daily Volume (90 D): |
1.89M |
Trade Size |
Avg Trade Size (Sh.): |
124 |
Avg Trade Size (Sh.) (30 D): |
176 |
Avg Trade Size (Sh.) (90 D): |
177 |
Institutional Trades |
Total Inst.Trades: |
566 |
Avg Inst. Trade: |
$1.97M |
Avg Inst. Trade (30 D): |
$1.14M |
Avg Inst. Trade (90 D): |
$1.05M |
Avg Inst. Trade Volume: |
.16M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.5M |
Avg Closing Trade (30 D): |
$1.21M |
Avg Closing Trade (90 D): |
$.78M |
Avg Closing Volume: |
186.25K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-2.16
|
$-.62
|
$-.56
|
Diluted EPS
|
$-2.16
|
$-.62
|
$-.56
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -104.16M
|
$ -30.63M
|
$ -27.6M
|
Operating Income / Loss
|
$ -114.5M
|
$ -33.05M
|
$ -30.28M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 55.11M
|
$ -8.01M
|
$ 3.32M
|
PE Ratio
|
|
|
|
|